ANAB

AnaptysBio, Inc.

Stock · NASDAQ

Program summary

FieldValueAs ofSource
Current authorization$100m30-Sep-2610-Q filed 12-Nov-26
Remaining authorization$100mEST30-Sep-2610-Q filed 12-Nov-26
Program expiry31-Dec-2630-Sep-2610-Q filed 12-Nov-26
Repurchased last quarterNot found in filings—
Has used an ASRNo—

Remaining authorization is estimated: we derive it from reported spend, or convert a share authorization at the latest close. Check the linked filings.

Programs

Authorized onAuthorizedRemainingExpiresTerms
Not found in filings$100m$100mEST31-Dec-26In March 2026, our board of directors approved a stock repurchase program to repurchase up to $100.0 million of shares of our outstanding common stock, par value $0.001 per share (the “2026 Repurchase Program”).10-Q filed 12-Nov-26

Open-market repurchases

None reported in the filings we hold.

Filings through 30-Sep-26· checked 17-Nov-26